These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27532114)

  • 1. MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis.
    Mehdi MZ; Nagi AH; Naseem N
    Int Braz J Urol; 2016; 42(6):1121-1128. PubMed ID: 27532114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
    Rodins K; Cheale M; Coleman N; Fox SB
    Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers.
    Wojnar A; Kobierzycki C; Krolicka A; Pula B; Podhorska-Okolow M; Dziegiel P
    Folia Histochem Cytobiol; 2010 Sep; 48(3):442-6. PubMed ID: 21097442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome.
    Delahunt B; Bethwaite PB; Thornton A; Ribas JL
    Cancer; 1995 Jun; 75(11):2714-9. PubMed ID: 7743475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis.
    Cheville JC; Terrell RB; Cohen MB
    Mod Pathol; 1994 Sep; 7(7):794-800. PubMed ID: 7824516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
    Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
    Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical evaluation of Ki-67, PCNA and MCM2 proteins proliferation index (PI) in advanced gastric cancer.
    Czyzewska J; Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Bandurski R
    Folia Histochem Cytobiol; 2009; 47(2):289-96. PubMed ID: 19995716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The highest Fuhrman and WHO/ISUP grade influences the Ki-67 labeling index of those of grades 1 and 2 in clear cell renal cell carcinoma.
    Murase Y; Iwata H; Takahara T; Tsuzuki T
    Pathol Int; 2020 Dec; 70(12):984-991. PubMed ID: 32997867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma.
    Ronkainen H; Hirvikoski P; Kauppila S; Vaarala MH
    Oncol Rep; 2011 Jan; 25(1):129-33. PubMed ID: 21109967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the prognostic value of DNA ploidy and proliferation index (Ki-67) in renal cell carcinoma with venous thrombus].
    Rey D; Pfister C; Gobet F; Martinez S; Staerman F; Grise P
    Prog Urol; 2003 Dec; 13(6):1300-6. PubMed ID: 15000303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer.
    Gonzalez MA; Pinder SE; Callagy G; Vowler SL; Morris LS; Bird K; Bell JA; Laskey RA; Coleman N
    J Clin Oncol; 2003 Dec; 21(23):4306-13. PubMed ID: 14645419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.
    Dudderidge TJ; Stoeber K; Loddo M; Atkinson G; Fanshawe T; Griffiths DF; Williams GH
    Clin Cancer Res; 2005 Apr; 11(7):2510-7. PubMed ID: 15814627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic behavior of and p53 overexpression in multifocal renal cell carcinoma of clear cell type: an immunohistochemical study correlating grading, staging, and proliferation markers.
    Haitel A; Wiener HG; Blaschitz U; Marberger M; Susani M
    Cancer; 1999 Apr; 85(7):1593-8. PubMed ID: 10193951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma.
    Rioux-Leclercq N; Turlin B; Bansard J; Patard J; Manunta A; Moulinoux JP; Guillé F; Ramée MP; Lobel B
    Urology; 2000 Apr; 55(4):501-5. PubMed ID: 10736491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of MCM-2 in invasive breast carcinoma: a stereologic approach.
    Cobanoglu U; Mungan S; Gundogdu C; Ersoz S; Ozoran Y; Aydin F
    Bratisl Lek Listy; 2010; 111(1):45-9. PubMed ID: 20429312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell proliferation, apoptosis, angiogenesis and growth rate of incidentally found renal cell carcinoma.
    Oda T; Takahashi A; Miyao N; Yanase M; Masumori N; Itoh N; Sato MA; Kon S; Tsukamoto T
    Int J Urol; 2003 Jan; 10(1):13-8. PubMed ID: 12534920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas.
    Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Maj J; Dziegiel P
    Anticancer Res; 2015 Nov; 35(11):6017-26. PubMed ID: 26504025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minichromosome maintenance protein expression according to the grade of atypism in actinic keratosis.
    Shin JW; Kim YK; Cho KH
    Am J Dermatopathol; 2010 Dec; 32(8):794-8. PubMed ID: 20847638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
    Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
    Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma.
    Yildiz E; Gokce G; Kilicarslan H; Ayan S; Goze OF; Gultekin EY
    BJU Int; 2004 May; 93(7):1087-93. PubMed ID: 15142169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.